To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis

Osteosarcoma (OS), a primary malignant bone tumor, stems from bone marrow-derived mesenchymal stem cells (BMSCs) and/or committed osteoblast precursors. Distant metastases, in particular pulmonary and skeletal metastases, are common in patients with OS. Moreover, extensive resection of the primary t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chunfeng Xu, Mingjie Wang, Behrouz Zandieh-Doulabi, Wei Sun, Lingfei Wei, Yuelian Liu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/5c1ef495047f4f80804321d336b781c1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5c1ef495047f4f80804321d336b781c1
record_format dspace
spelling oai:doaj.org-article:5c1ef495047f4f80804321d336b781c12021-11-17T07:01:22ZTo B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis2296-634X10.3389/fcell.2021.740783https://doaj.org/article/5c1ef495047f4f80804321d336b781c12021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.740783/fullhttps://doaj.org/toc/2296-634XOsteosarcoma (OS), a primary malignant bone tumor, stems from bone marrow-derived mesenchymal stem cells (BMSCs) and/or committed osteoblast precursors. Distant metastases, in particular pulmonary and skeletal metastases, are common in patients with OS. Moreover, extensive resection of the primary tumor and bone metastases usually leads to bone defects in these patients. Bone morphogenic protein-2 (BMP-2) has been widely applied in bone regeneration with the rationale that BMP-2 promotes osteoblastic differentiation of BMSCs. Thus, BMP-2 might be useful after OS resection to repair bone defects. However, the potential tumorigenicity of BMP-2 remains a concern that has impeded the administration of BMP-2 in patients with OS and in populations susceptible to OS with severe bone deficiency (e.g., in patients with genetic mutation diseases and aberrant activities of bone metabolism). In fact, some studies have drawn the opposite conclusion about the effect of BMP-2 on OS progression. Given the roles of BMSCs in the origination of OS and osteogenesis, we hypothesized that the responses of BMSCs to BMP-2 in the tumor milieu may be responsible for OS development. This review focuses on the relationship among BMSCs, BMP-2, and OS cells; a better understanding of this relationship may elucidate the accurate mechanisms of actions of BMP-2 in osteosarcomagenesis and thereby pave the way for clinically safer and broader administration of BMP-2 in the future. For example, a low dosage of and a slow-release delivery strategy for BMP-2 are potential topics for exploration to treat OS.Chunfeng XuMingjie WangBehrouz Zandieh-DoulabiWei SunWei SunLingfei WeiLingfei WeiYuelian LiuFrontiers Media S.A.articleosteosarcomabone morphogenetic protein-2mesenchymal stem cellsosteogenic differentiationosteogenesistumor heterogeneityBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic osteosarcoma
bone morphogenetic protein-2
mesenchymal stem cells
osteogenic differentiation
osteogenesis
tumor heterogeneity
Biology (General)
QH301-705.5
spellingShingle osteosarcoma
bone morphogenetic protein-2
mesenchymal stem cells
osteogenic differentiation
osteogenesis
tumor heterogeneity
Biology (General)
QH301-705.5
Chunfeng Xu
Mingjie Wang
Behrouz Zandieh-Doulabi
Wei Sun
Wei Sun
Lingfei Wei
Lingfei Wei
Yuelian Liu
To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
description Osteosarcoma (OS), a primary malignant bone tumor, stems from bone marrow-derived mesenchymal stem cells (BMSCs) and/or committed osteoblast precursors. Distant metastases, in particular pulmonary and skeletal metastases, are common in patients with OS. Moreover, extensive resection of the primary tumor and bone metastases usually leads to bone defects in these patients. Bone morphogenic protein-2 (BMP-2) has been widely applied in bone regeneration with the rationale that BMP-2 promotes osteoblastic differentiation of BMSCs. Thus, BMP-2 might be useful after OS resection to repair bone defects. However, the potential tumorigenicity of BMP-2 remains a concern that has impeded the administration of BMP-2 in patients with OS and in populations susceptible to OS with severe bone deficiency (e.g., in patients with genetic mutation diseases and aberrant activities of bone metabolism). In fact, some studies have drawn the opposite conclusion about the effect of BMP-2 on OS progression. Given the roles of BMSCs in the origination of OS and osteogenesis, we hypothesized that the responses of BMSCs to BMP-2 in the tumor milieu may be responsible for OS development. This review focuses on the relationship among BMSCs, BMP-2, and OS cells; a better understanding of this relationship may elucidate the accurate mechanisms of actions of BMP-2 in osteosarcomagenesis and thereby pave the way for clinically safer and broader administration of BMP-2 in the future. For example, a low dosage of and a slow-release delivery strategy for BMP-2 are potential topics for exploration to treat OS.
format article
author Chunfeng Xu
Mingjie Wang
Behrouz Zandieh-Doulabi
Wei Sun
Wei Sun
Lingfei Wei
Lingfei Wei
Yuelian Liu
author_facet Chunfeng Xu
Mingjie Wang
Behrouz Zandieh-Doulabi
Wei Sun
Wei Sun
Lingfei Wei
Lingfei Wei
Yuelian Liu
author_sort Chunfeng Xu
title To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
title_short To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
title_full To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
title_fullStr To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
title_full_unstemmed To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
title_sort to b (bone morphogenic protein-2) or not to b (bone morphogenic protein-2): mesenchymal stem cells may explain the protein’s role in osteosarcomagenesis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5c1ef495047f4f80804321d336b781c1
work_keys_str_mv AT chunfengxu tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
AT mingjiewang tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
AT behrouzzandiehdoulabi tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
AT weisun tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
AT weisun tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
AT lingfeiwei tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
AT lingfeiwei tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
AT yuelianliu tobbonemorphogenicprotein2ornottobbonemorphogenicprotein2mesenchymalstemcellsmayexplaintheproteinsroleinosteosarcomagenesis
_version_ 1718425859997564928